Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αvβ5 Axis
Zhe Zhu, Pinar Mesci, Jean Bernatchez, et al.
Cell stem cell (2020) Vol. 26, Iss. 2, pp. 187-204.e10
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

The continued threat of emerging flaviviruses
Theodore C. Pierson, Michael Diamond
Nature Microbiology (2020) Vol. 5, Iss. 6, pp. 796-812
Open Access | Times Cited: 825
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis
Qi Cui, Kailin Yin, Xiaoting Zhang, et al.
Nature Cancer (2021) Vol. 2, Iss. 9, pp. 932-949
Open Access | Times Cited: 108
Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 66
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Signaling pathways in brain tumors and therapeutic interventions
Shenglan Li, Can Wang, Jinyi Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Immunotherapy in glioblastoma treatment: Current state and future prospects
Samuel Luca Rocha Pinheiro, Fabian Fellipe Bueno Lemos, Hanna Santos Marques, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 4, pp. 138-159
Open Access | Times Cited: 51
Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access | Times Cited: 3
The adaptive transition of glioblastoma stem cells and its implications on treatments
Zeyu Wang, Hao Zhang, Shengchao Xu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Glioblastoma Immune Landscape and the Potential of New Immunotherapies
Thomas Daubon, Audrey Hémadou, Irati Romero‐Garmendia, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 94
Patient-Derived Organoids for Precision Cancer Immunotherapy
Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, et al.
Cancer Research (2021) Vol. 81, Iss. 12, pp. 3149-3155
Open Access | Times Cited: 86
The Application of Brain Organoids: From Neuronal Development to Neurological Diseases
Yikai Shou, Feng Liang, Shunliang Xu, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 80
Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
Bernarda Majc, Metka Novak, Nataša Kopitar‐Jerala, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 265-265
Open Access | Times Cited: 71
Integrins regulate stemness in solid tumor: an emerging therapeutic target
Jiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 64
TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling
Peng Peng, Hongtao Zhu, Dan Liu, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4221-4236
Open Access | Times Cited: 63
Association between Viral Infections and Risk of Autistic Disorder: An Overview
Ahmad Naqib Shuid, Putri Ayu Jayusman, Nazrun Shuid, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 6, pp. 2817-2817
Open Access | Times Cited: 61
The key amino acids of E protein involved in early flavivirus infection: viral entry
Tao Hu, Zhen Wu, Shaoxiong Wu, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 61
Immunotherapy of glioblastoma: Recent advances and future prospects
Boyang Yuan, Guoqing Wang, Xin Tang, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 55
Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence
Daniel Kreatsoulas, Chelsea Bolyard, Bill X. Wu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 49
SARS-CoV-2 infects human brain organoids causing cell death and loss of synapses that can be rescued by treatment with Sofosbuvir
Pinar Mesci, Janaína Sena de Souza, Laura Martin‐Sancho, et al.
PLoS Biology (2022) Vol. 20, Iss. 11, pp. e3001845-e3001845
Open Access | Times Cited: 46
CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway
Xinggang Mao, Xiaoyan Xue, Rui Lv, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 36
Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
Shashi Gujar, Jonathan Pol, K. Vishnupriyan, et al.
Nature Protocols (2024) Vol. 19, Iss. 9, pp. 2540-2570
Closed Access | Times Cited: 15
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
The hidden architects of glioblastoma multiforme: Glioma stem cells
Om Saswat Sahoo, Rhiti Mitra, Naveen KH Nagaiah
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens
Nicole M. Mattson, Anthony K. N. Chan, Kazuya Miyashita, et al.
Nature Structural & Molecular Biology (2024) Vol. 31, Iss. 3, pp. 465-475
Open Access | Times Cited: 9
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top